747 results on '"Meijers, Joost C. M."'
Search Results
2. Correction to: Coagulation in gout: is there a link with disease activity?
3. Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior
4. Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study
5. Brain Expression of CPB2 and Effects of Cpb2 Deficiency in Mouse Models of Behavior.
6. Elevated factor VIII increases the risk of cerebral venous thrombosis: a case–control study
7. Blood Coagulation and Beyond: Position Paper from the Fourth Maastricht Consensus Conference on Thrombosis
8. Coagulopathy in Zellweger spectrum disorders: a role for vitamin K
9. Structures of factor XI and prekallikrein bound to domain 6 of high–molecular weight kininogen reveal alternate domain 6 conformations and exosites
10. Circulating activated protein C in thrombophilia carriers
11. How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey
12. The Influence of Plasma Prekallikrein Oligonucleotide Antisense Therapy on Coagulation and Fibrinolysis Assays: A Post-hoc Analysis
13. Correction to:Coagulation in gout: is there a link with disease activity? (Clinical Rheumatology, (2022), 41, 6, (1809-1815), 10.1007/s10067-022-06047-9)
14. Platelet Activation via Glycoprotein VI Initiates Thrombin Generation: A Potential Role for Platelet-Derived Factor IX?
15. Impact of HIV infection on the haemostatic response during sepsis and malaria
16. Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen
17. VhH anti-thrombomodulin clone 1 inhibits TAFI activation and enhances fibrinolysis in human whole blood under flow
18. Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma
19. Plasminogen activator inhibitor-1 influences cerebrovascular complications and death in pneumococcal meningitis
20. In vivo reversal of the anticoagulant effect of rivaroxaban with four-factor prothrombin complex concentrate
21. Effects of IC14, an Anti-CD14 Antibody, on Coagulation and Fibrinolysis during Low-Grade Endotoxemia in Humans
22. Coagulation activation during air travel is not initiated via the extrinsic pathway
23. No association between Annexin A5 genetic variants and deep venous thrombosis
24. Development of a Hypercoagulable Status in Patients Undergoing Off-Pump Lung Transplantation despite Prolonged Conventional Coagulation Tests
25. Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study
26. Aprotinin Inhibits Thrombin Generation by Inhibition of the Intrinsic Pathway, but is not a Direct Thrombin Inhibitor
27. Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex
28. Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex
29. Characterization of the H-kininogen-binding site on factor XI: a comparison of factor XI and plasma prekallikrein
30. Recombinant C1-Inhibitor: Effects on Coagulation and Fibrinolysis in Patients with Hereditary Angioedema
31. Clinical practice: The bleeding child. Part II: Disorders of secondary hemostasis and fibrinolysis
32. Acute Stress Elicited by Bungee Jumping Suppresses Human Innate Immunity
33. Expression patterns of protein C inhibitor in mouse development
34. Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen
35. Complement C5 Contributes to Brain Injury After Subarachnoid Hemorrhage
36. Complement C5 Contributes to Brain Injury After Subarachnoid Hemorrhage
37. Hydrogen-deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa
38. Alveolar fibrinolytic capacity suppressed by injurious mechanical ventilation
39. Endogenous α2-Antiplasmin Is Protective during Severe Gram-Negative Sepsis (Melioidosis)
40. Decreased tissue factor pathway inhibitor (TFPI)-dependent anticoagulant capacity in patients with cirrhosis who have decreased protein S but normal TFPI plasma levels
41. Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients
42. An Unbalance Between von Willebrand Factor and ADAMTS13 in Acute Liver Failure: Implications for Hemostasis and Clinical Outcome
43. Factor XIII Val34Leu mutation and liver fibrosis rate in viral hepatitis
44. Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor
45. Factor XIII Val34Leu mutation accelerates the development of fibrosis in patients with chronic hepatitis B and C
46. Correction: Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis
47. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability
48. C4b-binding protein protects coagulation factor Va from inactivation by activated protein C
49. Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIα
50. Binding of amyloid β precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.